Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Myeloid, Acute | 71 | 2024 | 533 | 12.890 |
Why?
|
Neoplastic Stem Cells | 45 | 2023 | 326 | 10.930 |
Why?
|
Leukemia | 21 | 2021 | 208 | 5.430 |
Why?
|
Sesquiterpenes | 25 | 2024 | 51 | 4.010 |
Why?
|
Bridged Bicyclo Compounds, Heterocyclic | 15 | 2024 | 173 | 3.780 |
Why?
|
Hematopoietic Stem Cells | 36 | 2021 | 337 | 3.160 |
Why?
|
Sulfonamides | 14 | 2024 | 442 | 2.850 |
Why?
|
Antineoplastic Agents | 31 | 2021 | 1872 | 2.530 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 22 | 2024 | 1356 | 2.260 |
Why?
|
Azacitidine | 13 | 2024 | 130 | 1.930 |
Why?
|
Drug Delivery Systems | 4 | 2019 | 293 | 1.520 |
Why?
|
Cell Self Renewal | 3 | 2022 | 49 | 1.420 |
Why?
|
Myelodysplastic Syndromes | 9 | 2020 | 119 | 1.410 |
Why?
|
Oxidative Phosphorylation | 7 | 2022 | 154 | 1.360 |
Why?
|
Drug Resistance, Neoplasm | 13 | 2022 | 636 | 1.340 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 4 | 2019 | 207 | 1.280 |
Why?
|
Stem Cells | 10 | 2020 | 538 | 1.240 |
Why?
|
Gene Expression Regulation, Leukemic | 8 | 2016 | 48 | 1.180 |
Why?
|
Leukemia, Myeloid | 7 | 2011 | 40 | 1.140 |
Why?
|
Cell Transformation, Neoplastic | 7 | 2018 | 305 | 1.040 |
Why?
|
Mice | 65 | 2024 | 14679 | 1.010 |
Why?
|
Animals | 85 | 2024 | 31162 | 0.990 |
Why?
|
Humans | 145 | 2024 | 113531 | 0.960 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 5 | 2013 | 297 | 0.920 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2022 | 41 | 0.840 |
Why?
|
NF-kappa B | 13 | 2024 | 615 | 0.800 |
Why?
|
Electron Transport Complex II | 2 | 2019 | 23 | 0.800 |
Why?
|
Amino Acid Transport System ASC | 1 | 2022 | 10 | 0.780 |
Why?
|
Cytarabine | 5 | 2019 | 51 | 0.770 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2022 | 115 | 0.770 |
Why?
|
Fatty Acids | 3 | 2020 | 380 | 0.760 |
Why?
|
Apoptosis | 21 | 2024 | 2288 | 0.760 |
Why?
|
Tumor Cells, Cultured | 16 | 2022 | 834 | 0.750 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2018 | 256 | 0.730 |
Why?
|
Signal Transduction | 17 | 2022 | 4439 | 0.720 |
Why?
|
Cell Survival | 19 | 2022 | 1004 | 0.720 |
Why?
|
AMP-Activated Protein Kinases | 2 | 2020 | 170 | 0.710 |
Why?
|
Mice, Inbred NOD | 16 | 2020 | 551 | 0.710 |
Why?
|
Lipase | 1 | 2020 | 55 | 0.700 |
Why?
|
STAT3 Transcription Factor | 1 | 2022 | 171 | 0.700 |
Why?
|
Neoplasm Proteins | 5 | 2016 | 381 | 0.690 |
Why?
|
Antigens, CD34 | 10 | 2023 | 87 | 0.690 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 7 | 2016 | 93 | 0.680 |
Why?
|
Blast Crisis | 6 | 2016 | 20 | 0.680 |
Why?
|
Cell Line, Tumor | 26 | 2024 | 2690 | 0.670 |
Why?
|
Aldehyde Dehydrogenase | 3 | 2017 | 102 | 0.660 |
Why?
|
Glutathione | 4 | 2019 | 291 | 0.650 |
Why?
|
Leukopoiesis | 1 | 2019 | 10 | 0.650 |
Why?
|
Myeloid Progenitor Cells | 1 | 2019 | 15 | 0.640 |
Why?
|
Mice, SCID | 15 | 2020 | 311 | 0.640 |
Why?
|
NADPH Oxidase 2 | 1 | 2019 | 37 | 0.640 |
Why?
|
Flow Cytometry | 13 | 2020 | 1065 | 0.630 |
Why?
|
Amino Acids | 2 | 2020 | 443 | 0.630 |
Why?
|
Cysteine | 1 | 2019 | 172 | 0.600 |
Why?
|
Reactive Oxygen Species | 7 | 2020 | 516 | 0.580 |
Why?
|
Hematopoiesis | 11 | 2015 | 170 | 0.570 |
Why?
|
Mice, Inbred C57BL | 23 | 2021 | 4617 | 0.570 |
Why?
|
Energy Metabolism | 5 | 2021 | 717 | 0.560 |
Why?
|
Mitochondrial Proteins | 2 | 2018 | 212 | 0.550 |
Why?
|
Cell Proliferation | 16 | 2021 | 2164 | 0.550 |
Why?
|
Gene Expression Profiling | 4 | 2014 | 1510 | 0.550 |
Why?
|
Protein Kinase Inhibitors | 7 | 2022 | 779 | 0.540 |
Why?
|
Neoplasms | 7 | 2015 | 2082 | 0.540 |
Why?
|
Interleukin-3 Receptor alpha Subunit | 4 | 2019 | 17 | 0.540 |
Why?
|
Liver | 7 | 2020 | 1630 | 0.530 |
Why?
|
Triterpenes | 2 | 2014 | 17 | 0.520 |
Why?
|
Homeostasis | 2 | 2021 | 561 | 0.520 |
Why?
|
Xenograft Model Antitumor Assays | 15 | 2020 | 693 | 0.510 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2016 | 71 | 0.510 |
Why?
|
fms-Like Tyrosine Kinase 3 | 8 | 2022 | 42 | 0.510 |
Why?
|
Sirolimus | 5 | 2016 | 181 | 0.510 |
Why?
|
Oxidation-Reduction | 6 | 2019 | 912 | 0.500 |
Why?
|
Membrane Proteins | 5 | 2018 | 1008 | 0.470 |
Why?
|
Cells, Cultured | 12 | 2019 | 3802 | 0.470 |
Why?
|
Benzofurans | 1 | 2014 | 18 | 0.450 |
Why?
|
Phosphoproteins | 3 | 2020 | 291 | 0.450 |
Why?
|
Thiadiazoles | 3 | 2011 | 21 | 0.450 |
Why?
|
Dioxolanes | 1 | 2013 | 6 | 0.440 |
Why?
|
Transduction, Genetic | 7 | 2006 | 112 | 0.440 |
Why?
|
Glucose | 1 | 2018 | 894 | 0.430 |
Why?
|
Antibodies, Monoclonal | 8 | 2020 | 1236 | 0.430 |
Why?
|
Mutation | 8 | 2024 | 3313 | 0.430 |
Why?
|
Fusion Proteins, bcr-abl | 4 | 2014 | 60 | 0.420 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2022 | 357 | 0.420 |
Why?
|
Oxidative Stress | 4 | 2014 | 1065 | 0.420 |
Why?
|
Adaptation, Physiological | 1 | 2016 | 465 | 0.410 |
Why?
|
Adipose Tissue | 1 | 2016 | 537 | 0.410 |
Why?
|
Cell Death | 8 | 2012 | 320 | 0.390 |
Why?
|
Oncogenes | 1 | 2012 | 104 | 0.390 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2008 | 57 | 0.380 |
Why?
|
Adenoviridae | 3 | 2001 | 179 | 0.370 |
Why?
|
Succinate Dehydrogenase | 3 | 2022 | 41 | 0.370 |
Why?
|
Proto-Oncogene Proteins | 8 | 2021 | 595 | 0.360 |
Why?
|
Cell Differentiation | 14 | 2022 | 1681 | 0.360 |
Why?
|
Neoplasm, Residual | 4 | 2024 | 105 | 0.360 |
Why?
|
Gene Transfer Techniques | 4 | 2001 | 144 | 0.350 |
Why?
|
Insulin Resistance | 1 | 2018 | 1068 | 0.350 |
Why?
|
Bone Marrow | 6 | 2020 | 242 | 0.350 |
Why?
|
Hematopoietic Stem Cell Transplantation | 8 | 2022 | 512 | 0.340 |
Why?
|
Antineoplastic Agents, Phytogenic | 2 | 2015 | 180 | 0.340 |
Why?
|
Enzyme Inhibitors | 3 | 2010 | 737 | 0.340 |
Why?
|
Disease Models, Animal | 10 | 2020 | 3470 | 0.330 |
Why?
|
Bone Marrow Cells | 10 | 2020 | 262 | 0.330 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2013 | 178 | 0.330 |
Why?
|
RNA Splicing Factors | 2 | 2020 | 49 | 0.330 |
Why?
|
Leukemia, Experimental | 2 | 2006 | 27 | 0.330 |
Why?
|
Indoles | 3 | 2017 | 296 | 0.320 |
Why?
|
Antigens, CD | 6 | 2010 | 437 | 0.320 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2009 | 46 | 0.320 |
Why?
|
Multiple Myeloma | 2 | 2020 | 98 | 0.320 |
Why?
|
Structure-Activity Relationship | 9 | 2021 | 497 | 0.320 |
Why?
|
Hematologic Neoplasms | 3 | 2017 | 132 | 0.310 |
Why?
|
Lymphoid Progenitor Cells | 1 | 2008 | 11 | 0.310 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2010 | 324 | 0.310 |
Why?
|
Dose-Response Relationship, Drug | 9 | 2019 | 1822 | 0.310 |
Why?
|
Drug Screening Assays, Antitumor | 9 | 2021 | 181 | 0.300 |
Why?
|
Female | 36 | 2024 | 59115 | 0.280 |
Why?
|
Genetic Vectors | 5 | 2001 | 285 | 0.280 |
Why?
|
Stem Cell Transplantation | 2 | 2005 | 144 | 0.280 |
Why?
|
Hematopoietic System | 1 | 2006 | 8 | 0.270 |
Why?
|
Drug Design | 4 | 2016 | 146 | 0.270 |
Why?
|
Tumor Burden | 3 | 2016 | 257 | 0.260 |
Why?
|
Tanacetum parthenium | 1 | 2005 | 1 | 0.250 |
Why?
|
Myeloid Cells | 1 | 2006 | 125 | 0.250 |
Why?
|
Mice, Transgenic | 5 | 2019 | 1925 | 0.250 |
Why?
|
Neoplasm Transplantation | 5 | 2016 | 227 | 0.250 |
Why?
|
Tumor Microenvironment | 4 | 2022 | 428 | 0.240 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2018 | 1140 | 0.240 |
Why?
|
Molecular Targeted Therapy | 5 | 2019 | 345 | 0.230 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 848 | 0.230 |
Why?
|
Cell Lineage | 4 | 2012 | 305 | 0.230 |
Why?
|
Histiocytic Sarcoma | 1 | 2024 | 3 | 0.230 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2014 | 443 | 0.230 |
Why?
|
Hemangiosarcoma | 1 | 2024 | 18 | 0.220 |
Why?
|
Models, Biological | 6 | 2011 | 1589 | 0.220 |
Why?
|
Prognosis | 7 | 2024 | 3318 | 0.220 |
Why?
|
Interferon Regulatory Factors | 2 | 2020 | 31 | 0.220 |
Why?
|
Pyrimidines | 2 | 2017 | 372 | 0.210 |
Why?
|
Cell Cycle | 4 | 2021 | 538 | 0.210 |
Why?
|
Retroviridae | 6 | 2006 | 89 | 0.210 |
Why?
|
Pyrroles | 2 | 2015 | 179 | 0.210 |
Why?
|
Drug Discovery | 3 | 2013 | 122 | 0.210 |
Why?
|
Spliceosomes | 2 | 2020 | 38 | 0.200 |
Why?
|
Immunophenotyping | 5 | 2016 | 272 | 0.200 |
Why?
|
Serine-Arginine Splicing Factors | 2 | 2019 | 18 | 0.200 |
Why?
|
Aged, 80 and over | 8 | 2024 | 6296 | 0.200 |
Why?
|
Niacinamide | 2 | 2020 | 63 | 0.190 |
Why?
|
Osteoblasts | 4 | 2012 | 106 | 0.190 |
Why?
|
Mice, Knockout | 7 | 2016 | 2523 | 0.190 |
Why?
|
Disease Progression | 5 | 2023 | 2364 | 0.190 |
Why?
|
Drug Synergism | 5 | 2020 | 312 | 0.190 |
Why?
|
Male | 29 | 2024 | 55112 | 0.190 |
Why?
|
Transplantation, Heterologous | 3 | 2010 | 180 | 0.190 |
Why?
|
Aged | 11 | 2024 | 18944 | 0.190 |
Why?
|
Forkhead Transcription Factors | 2 | 2019 | 169 | 0.190 |
Why?
|
c-Mer Tyrosine Kinase | 2 | 2018 | 42 | 0.180 |
Why?
|
Trans-Activators | 2 | 2021 | 356 | 0.180 |
Why?
|
Genes, Tumor Suppressor | 1 | 2001 | 78 | 0.180 |
Why?
|
Receptors, Interleukin-3 | 1 | 2000 | 5 | 0.180 |
Why?
|
Nuclear Receptor Co-Repressor 2 | 1 | 2020 | 14 | 0.180 |
Why?
|
Bone Marrow Diseases | 1 | 2020 | 18 | 0.180 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2015 | 97 | 0.180 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2020 | 40 | 0.180 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2001 | 167 | 0.180 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2015 | 914 | 0.180 |
Why?
|
Nuclear Proteins | 3 | 2018 | 584 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2020 | 51 | 0.170 |
Why?
|
Inflammation | 3 | 2021 | 2444 | 0.170 |
Why?
|
Repressor Proteins | 2 | 2020 | 358 | 0.170 |
Why?
|
Graft vs Host Disease | 1 | 2022 | 210 | 0.170 |
Why?
|
Cell Separation | 5 | 2011 | 288 | 0.170 |
Why?
|
Molecular Structure | 6 | 2018 | 429 | 0.170 |
Why?
|
Decision Support Systems, Clinical | 1 | 2022 | 176 | 0.170 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 131 | 0.170 |
Why?
|
Cytochrome P-450 Enzyme System | 3 | 2016 | 108 | 0.170 |
Why?
|
Cell-Derived Microparticles | 1 | 2020 | 54 | 0.160 |
Why?
|
Receptor Protein-Tyrosine Kinases | 4 | 2015 | 223 | 0.160 |
Why?
|
HEK293 Cells | 2 | 2019 | 585 | 0.160 |
Why?
|
Bone Marrow Transplantation | 3 | 2016 | 234 | 0.160 |
Why?
|
Splicing Factor U2AF | 1 | 2019 | 16 | 0.160 |
Why?
|
Tricarboxylic Acids | 1 | 2018 | 10 | 0.160 |
Why?
|
Ketoglutaric Acids | 1 | 2018 | 15 | 0.160 |
Why?
|
Histone Deacetylases | 1 | 2020 | 194 | 0.160 |
Why?
|
Blotting, Western | 5 | 2015 | 1128 | 0.160 |
Why?
|
Cytokines | 7 | 2020 | 1795 | 0.160 |
Why?
|
Glutamine | 1 | 2019 | 90 | 0.150 |
Why?
|
Thrombocytopenia | 1 | 2020 | 175 | 0.150 |
Why?
|
Protein Biosynthesis | 1 | 2020 | 375 | 0.150 |
Why?
|
Biomarkers, Tumor | 4 | 2016 | 1029 | 0.150 |
Why?
|
Genes | 1 | 1998 | 220 | 0.150 |
Why?
|
Cytoprotection | 2 | 2016 | 51 | 0.150 |
Why?
|
Salvage Therapy | 1 | 2019 | 125 | 0.150 |
Why?
|
Stress, Physiological | 1 | 2021 | 375 | 0.150 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 2 | 2016 | 62 | 0.150 |
Why?
|
RNA Interference | 3 | 2015 | 426 | 0.150 |
Why?
|
DNA Methylation | 2 | 2015 | 493 | 0.150 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2008 | 56 | 0.150 |
Why?
|
Phenotype | 4 | 2019 | 2754 | 0.150 |
Why?
|
Gene Expression | 5 | 2020 | 1397 | 0.150 |
Why?
|
Phosphorylation | 5 | 2022 | 1537 | 0.150 |
Why?
|
Clinical Trials as Topic | 2 | 2014 | 922 | 0.140 |
Why?
|
Biological Transport | 1 | 2018 | 363 | 0.140 |
Why?
|
Students, Medical | 1 | 2021 | 260 | 0.140 |
Why?
|
Arthritis, Experimental | 1 | 2019 | 123 | 0.140 |
Why?
|
Transcriptome | 4 | 2022 | 719 | 0.140 |
Why?
|
Recombinational DNA Repair | 1 | 2017 | 9 | 0.140 |
Why?
|
Glycolysis | 1 | 2018 | 223 | 0.140 |
Why?
|
Succinates | 1 | 2017 | 18 | 0.140 |
Why?
|
Immunotherapy, Adoptive | 1 | 2019 | 184 | 0.140 |
Why?
|
Drug Therapy, Combination | 2 | 2017 | 944 | 0.140 |
Why?
|
Carboxylic Acids | 1 | 2017 | 26 | 0.140 |
Why?
|
Triazoles | 1 | 2018 | 123 | 0.140 |
Why?
|
Lipid Metabolism | 2 | 2018 | 438 | 0.140 |
Why?
|
Diet, High-Fat | 1 | 2018 | 224 | 0.140 |
Why?
|
Immunity, Innate | 2 | 2021 | 716 | 0.140 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2010 | 739 | 0.140 |
Why?
|
Boronic Acids | 3 | 2013 | 33 | 0.140 |
Why?
|
RNA, Messenger | 8 | 2011 | 2507 | 0.140 |
Why?
|
Phthalazines | 1 | 2017 | 38 | 0.140 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 426 | 0.140 |
Why?
|
Proteasome Inhibitors | 2 | 2020 | 41 | 0.140 |
Why?
|
Esters | 1 | 2017 | 62 | 0.140 |
Why?
|
Programmed Cell Death 1 Receptor | 1 | 2018 | 193 | 0.140 |
Why?
|
Genomics | 2 | 2018 | 625 | 0.140 |
Why?
|
Sulfhydryl Compounds | 2 | 2009 | 176 | 0.130 |
Why?
|
Pyrazines | 3 | 2013 | 70 | 0.130 |
Why?
|
Benzothiazoles | 2 | 2016 | 31 | 0.130 |
Why?
|
Amides | 1 | 2017 | 87 | 0.130 |
Why?
|
Genome, Human | 1 | 2018 | 342 | 0.130 |
Why?
|
NADP | 1 | 2016 | 42 | 0.130 |
Why?
|
Adenoviruses, Human | 1 | 1996 | 24 | 0.130 |
Why?
|
Phenylacetates | 1 | 2016 | 9 | 0.130 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 62 | 0.130 |
Why?
|
Deoxyglucose | 1 | 2016 | 43 | 0.130 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 2016 | 36 | 0.130 |
Why?
|
Gonads | 1 | 2016 | 21 | 0.130 |
Why?
|
CD36 Antigens | 1 | 2016 | 34 | 0.130 |
Why?
|
Acute Disease | 4 | 2005 | 885 | 0.130 |
Why?
|
DNA-Binding Proteins | 2 | 2013 | 1286 | 0.130 |
Why?
|
Recurrence | 5 | 2022 | 925 | 0.130 |
Why?
|
Lipolysis | 1 | 2016 | 39 | 0.130 |
Why?
|
Transcription Factors | 5 | 2022 | 1497 | 0.130 |
Why?
|
Camptothecin | 1 | 2016 | 95 | 0.130 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 379 | 0.130 |
Why?
|
Neoplasms, Experimental | 2 | 2016 | 149 | 0.130 |
Why?
|
Oncogene Proteins | 1 | 2016 | 53 | 0.130 |
Why?
|
Neoplasms, Plasma Cell | 1 | 2015 | 7 | 0.130 |
Why?
|
Metabolome | 1 | 2018 | 275 | 0.130 |
Why?
|
Cell Division | 5 | 2004 | 745 | 0.130 |
Why?
|
Leukocytosis | 1 | 2015 | 34 | 0.130 |
Why?
|
Transplantation, Homologous | 4 | 2010 | 373 | 0.130 |
Why?
|
Up-Regulation | 2 | 2016 | 794 | 0.130 |
Why?
|
Fetal Tissue Transplantation | 1 | 1995 | 33 | 0.130 |
Why?
|
Methyltransferases | 1 | 2016 | 61 | 0.120 |
Why?
|
Clonal Evolution | 1 | 2015 | 25 | 0.120 |
Why?
|
Membrane Glycoproteins | 5 | 2004 | 420 | 0.120 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2015 | 13 | 0.120 |
Why?
|
Lactones | 3 | 2021 | 53 | 0.120 |
Why?
|
Computational Biology | 1 | 2019 | 527 | 0.120 |
Why?
|
Molecular Docking Simulation | 3 | 2021 | 101 | 0.120 |
Why?
|
Doxycycline | 1 | 2015 | 53 | 0.120 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2014 | 197 | 0.120 |
Why?
|
Homeodomain Proteins | 5 | 2016 | 460 | 0.120 |
Why?
|
Cell Membrane | 2 | 2009 | 663 | 0.120 |
Why?
|
Oligomycins | 1 | 2014 | 7 | 0.120 |
Why?
|
Piperazines | 1 | 2017 | 309 | 0.120 |
Why?
|
Remission Induction | 4 | 2019 | 233 | 0.120 |
Why?
|
Mitochondrial Proton-Translocating ATPases | 1 | 2014 | 17 | 0.120 |
Why?
|
Dogs | 2 | 2024 | 325 | 0.120 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2016 | 96 | 0.120 |
Why?
|
Biomarkers | 2 | 2019 | 3389 | 0.120 |
Why?
|
Transcription Factor RelA | 2 | 2021 | 75 | 0.120 |
Why?
|
Peptide Hydrolases | 1 | 2015 | 102 | 0.120 |
Why?
|
Glucuronosyltransferase | 1 | 2014 | 9 | 0.120 |
Why?
|
Eukaryotic Initiation Factor-4E | 2 | 2005 | 26 | 0.120 |
Why?
|
Glucuronic Acid | 1 | 2014 | 25 | 0.120 |
Why?
|
Osteoclasts | 2 | 2011 | 34 | 0.120 |
Why?
|
Phenylbutyrates | 1 | 2014 | 21 | 0.120 |
Why?
|
Necrosis | 1 | 2015 | 210 | 0.120 |
Why?
|
I-kappa B Kinase | 1 | 2014 | 49 | 0.110 |
Why?
|
Selenium | 1 | 2014 | 31 | 0.110 |
Why?
|
Pyrazoles | 1 | 2017 | 361 | 0.110 |
Why?
|
Multiprotein Complexes | 1 | 2015 | 140 | 0.110 |
Why?
|
Thiamine | 1 | 2014 | 11 | 0.110 |
Why?
|
Eicosanoids | 1 | 2014 | 52 | 0.110 |
Why?
|
Genetic Heterogeneity | 1 | 2014 | 47 | 0.110 |
Why?
|
Glutamate-Cysteine Ligase | 1 | 2013 | 14 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 283 | 0.110 |
Why?
|
Glutathione Peroxidase | 1 | 2013 | 40 | 0.110 |
Why?
|
Integrin beta3 | 1 | 2013 | 5 | 0.110 |
Why?
|
Hydrolases | 1 | 2014 | 51 | 0.110 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2014 | 109 | 0.110 |
Why?
|
Breast Neoplasms | 2 | 2015 | 1842 | 0.110 |
Why?
|
Hedgehog Proteins | 1 | 2014 | 171 | 0.100 |
Why?
|
Survival Rate | 3 | 2019 | 1634 | 0.100 |
Why?
|
Tyrphostins | 1 | 2012 | 13 | 0.100 |
Why?
|
Carrier Proteins | 2 | 2015 | 685 | 0.100 |
Why?
|
Serpins | 1 | 2012 | 24 | 0.100 |
Why?
|
Treatment Outcome | 6 | 2024 | 9006 | 0.100 |
Why?
|
Antifungal Agents | 1 | 2013 | 125 | 0.100 |
Why?
|
Spleen | 3 | 2011 | 480 | 0.100 |
Why?
|
Mice, Inbred Strains | 3 | 2006 | 394 | 0.100 |
Why?
|
Pyridones | 1 | 2013 | 122 | 0.100 |
Why?
|
Mitochondria | 2 | 2014 | 735 | 0.100 |
Why?
|
Retrospective Studies | 7 | 2024 | 12504 | 0.100 |
Why?
|
Chemokine CCL3 | 1 | 2011 | 15 | 0.100 |
Why?
|
Nitrogen Mustard Compounds | 1 | 2011 | 6 | 0.100 |
Why?
|
Software | 1 | 2015 | 525 | 0.100 |
Why?
|
Middle Aged | 11 | 2024 | 26552 | 0.090 |
Why?
|
Receptors, Immunologic | 2 | 2009 | 195 | 0.090 |
Why?
|
Cellular Microenvironment | 1 | 2012 | 75 | 0.090 |
Why?
|
Leukocytes, Mononuclear | 1 | 2014 | 487 | 0.090 |
Why?
|
Tumor Stem Cell Assay | 2 | 2015 | 33 | 0.090 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 633 | 0.090 |
Why?
|
Prodrugs | 1 | 2011 | 42 | 0.090 |
Why?
|
ADP-ribosyl Cyclase 1 | 4 | 2009 | 36 | 0.090 |
Why?
|
Arthritis, Rheumatoid | 1 | 2019 | 996 | 0.090 |
Why?
|
Seminal Vesicles | 1 | 2010 | 8 | 0.090 |
Why?
|
Neutrophils | 1 | 2015 | 1072 | 0.090 |
Why?
|
Protease Inhibitors | 1 | 2011 | 96 | 0.090 |
Why?
|
Chemokine CXCL12 | 1 | 2011 | 74 | 0.090 |
Why?
|
Ethanol | 1 | 2015 | 532 | 0.090 |
Why?
|
Medication Adherence | 1 | 2015 | 530 | 0.090 |
Why?
|
Binding Sites | 3 | 2021 | 1153 | 0.090 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2010 | 158 | 0.090 |
Why?
|
Sialic Acid Binding Ig-like Lectin 3 | 1 | 2010 | 8 | 0.090 |
Why?
|
Base Sequence | 6 | 2013 | 2080 | 0.090 |
Why?
|
Genetic Markers | 3 | 1999 | 318 | 0.090 |
Why?
|
Graft vs Tumor Effect | 1 | 2010 | 8 | 0.090 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2010 | 53 | 0.090 |
Why?
|
Colony-Forming Units Assay | 4 | 2009 | 87 | 0.090 |
Why?
|
Receptors, Cell Surface | 3 | 2022 | 347 | 0.080 |
Why?
|
Hyaluronan Receptors | 1 | 2010 | 90 | 0.080 |
Why?
|
K562 Cells | 2 | 2020 | 73 | 0.080 |
Why?
|
Prostate | 1 | 2010 | 157 | 0.080 |
Why?
|
Kidney Transplantation | 1 | 2015 | 537 | 0.080 |
Why?
|
Protein Kinase C | 2 | 2007 | 247 | 0.080 |
Why?
|
Vidarabine | 1 | 2008 | 26 | 0.080 |
Why?
|
Polymerase Chain Reaction | 5 | 2024 | 984 | 0.080 |
Why?
|
Insulin | 1 | 2018 | 2076 | 0.080 |
Why?
|
Dinoprostone | 1 | 2009 | 178 | 0.080 |
Why?
|
Adult | 10 | 2024 | 30245 | 0.080 |
Why?
|
RNA, Small Interfering | 3 | 2016 | 528 | 0.080 |
Why?
|
Liver Transplantation | 1 | 1995 | 693 | 0.080 |
Why?
|
Radiation Oncology | 1 | 2009 | 74 | 0.080 |
Why?
|
Follow-Up Studies | 4 | 2019 | 4384 | 0.080 |
Why?
|
RNA Splicing | 2 | 2020 | 244 | 0.080 |
Why?
|
Lymphocytes | 3 | 1999 | 321 | 0.080 |
Why?
|
Induction Chemotherapy | 2 | 2021 | 55 | 0.080 |
Why?
|
Graft vs Leukemia Effect | 1 | 2008 | 12 | 0.080 |
Why?
|
Genetic Therapy | 2 | 2000 | 253 | 0.070 |
Why?
|
MutS Homolog 2 Protein | 1 | 2008 | 12 | 0.070 |
Why?
|
Mice, Nude | 3 | 2015 | 625 | 0.070 |
Why?
|
Pentacyclic Triterpenes | 1 | 2008 | 13 | 0.070 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2008 | 43 | 0.070 |
Why?
|
Terpenes | 1 | 2008 | 21 | 0.070 |
Why?
|
DNA Mismatch Repair | 1 | 2008 | 37 | 0.070 |
Why?
|
Primary Cell Culture | 2 | 2020 | 148 | 0.070 |
Why?
|
MicroRNAs | 1 | 2013 | 598 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2006 | 63 | 0.070 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2008 | 154 | 0.070 |
Why?
|
ADP-ribosyl Cyclase | 3 | 2004 | 4 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2010 | 342 | 0.070 |
Why?
|
Biological Availability | 1 | 2007 | 119 | 0.070 |
Why?
|
Mice, Inbred BALB C | 3 | 2016 | 1136 | 0.070 |
Why?
|
Bortezomib | 3 | 2013 | 41 | 0.070 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 64 | 0.070 |
Why?
|
Aldehydes | 1 | 2008 | 137 | 0.070 |
Why?
|
Receptors, LDL | 1 | 2007 | 38 | 0.070 |
Why?
|
Biomedical Research | 2 | 2010 | 581 | 0.070 |
Why?
|
Databases, Genetic | 1 | 2008 | 205 | 0.070 |
Why?
|
Phospholipases A | 1 | 2007 | 94 | 0.070 |
Why?
|
Receptors, Virus | 2 | 1997 | 75 | 0.070 |
Why?
|
Hodgkin Disease | 1 | 2008 | 121 | 0.070 |
Why?
|
Cell Line, Transformed | 1 | 2006 | 132 | 0.070 |
Why?
|
Exome | 2 | 2018 | 200 | 0.060 |
Why?
|
Coculture Techniques | 1 | 2006 | 198 | 0.060 |
Why?
|
Cohort Studies | 3 | 2022 | 4880 | 0.060 |
Why?
|
Clone Cells | 2 | 2001 | 245 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2009 | 1282 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 1 | 2008 | 383 | 0.060 |
Why?
|
Plants, Medicinal | 1 | 2005 | 19 | 0.060 |
Why?
|
Molecular Sequence Data | 5 | 2013 | 2741 | 0.060 |
Why?
|
Parathyroid Hormone | 1 | 2006 | 96 | 0.060 |
Why?
|
Receptors, Notch | 1 | 2006 | 83 | 0.060 |
Why?
|
Models, Genetic | 1 | 2008 | 542 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2011 | 1157 | 0.060 |
Why?
|
Protein Binding | 3 | 2020 | 1867 | 0.060 |
Why?
|
Myeloid Ecotropic Viral Integration Site 1 Protein | 2 | 2016 | 11 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2014 | 390 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 367 | 0.060 |
Why?
|
Gene Deletion | 2 | 2018 | 351 | 0.060 |
Why?
|
Calcium-Binding Proteins | 1 | 2006 | 201 | 0.060 |
Why?
|
Diphtheria Toxin | 1 | 2004 | 51 | 0.060 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2015 | 43 | 0.060 |
Why?
|
Drug Resistance | 1 | 2005 | 158 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2006 | 344 | 0.060 |
Why?
|
Oxides | 2 | 2017 | 40 | 0.060 |
Why?
|
Arsenicals | 2 | 2017 | 24 | 0.060 |
Why?
|
NAD+ Nucleosidase | 2 | 2001 | 2 | 0.060 |
Why?
|
Drug Evaluation | 1 | 2004 | 77 | 0.060 |
Why?
|
Inflammation Mediators | 2 | 2020 | 469 | 0.060 |
Why?
|
Stereoisomerism | 2 | 2016 | 90 | 0.060 |
Why?
|
Antigens, Differentiation | 2 | 2001 | 77 | 0.060 |
Why?
|
Phenylurea Compounds | 2 | 2016 | 81 | 0.050 |
Why?
|
Translocation, Genetic | 1 | 2004 | 92 | 0.050 |
Why?
|
Forecasting | 1 | 2005 | 329 | 0.050 |
Why?
|
Young Adult | 4 | 2021 | 10400 | 0.050 |
Why?
|
Cytomegalovirus | 1 | 2004 | 140 | 0.050 |
Why?
|
Maximum Tolerated Dose | 2 | 2013 | 182 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2007 | 342 | 0.050 |
Why?
|
Enzyme Activation | 3 | 2010 | 752 | 0.050 |
Why?
|
Heat Shock Transcription Factors | 1 | 2022 | 17 | 0.050 |
Why?
|
Rats | 4 | 2015 | 4829 | 0.050 |
Why?
|
Everolimus | 1 | 2022 | 61 | 0.050 |
Why?
|
Lentivirus | 2 | 2019 | 45 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 1783 | 0.050 |
Why?
|
Cytomegalovirus Infections | 1 | 2004 | 175 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2004 | 599 | 0.050 |
Why?
|
Biopsy | 2 | 2015 | 1024 | 0.050 |
Why?
|
Models, Molecular | 2 | 2018 | 1359 | 0.050 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2001 | 13 | 0.050 |
Why?
|
Death-Associated Protein Kinases | 1 | 2001 | 10 | 0.050 |
Why?
|
Enzyme Induction | 1 | 2001 | 81 | 0.050 |
Why?
|
Real-Time Polymerase Chain Reaction | 2 | 2012 | 310 | 0.050 |
Why?
|
Allografts | 1 | 2021 | 121 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2022 | 617 | 0.040 |
Why?
|
Megakaryocytes | 1 | 2020 | 29 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2001 | 168 | 0.040 |
Why?
|
Protein Domains | 1 | 2021 | 207 | 0.040 |
Why?
|
DNA | 4 | 2008 | 1331 | 0.040 |
Why?
|
Cell- and Tissue-Based Therapy | 1 | 2020 | 53 | 0.040 |
Why?
|
Macrophages | 2 | 2018 | 1233 | 0.040 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 1999 | 20 | 0.040 |
Why?
|
Mice, Inbred C3H | 2 | 1990 | 242 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2010 | 139 | 0.040 |
Why?
|
Cell Hypoxia | 2 | 2011 | 220 | 0.040 |
Why?
|
Radiation Chimera | 2 | 2008 | 29 | 0.040 |
Why?
|
Infection Control | 1 | 2000 | 130 | 0.040 |
Why?
|
Monocytes | 2 | 2018 | 499 | 0.040 |
Why?
|
Gene Expression Regulation, Viral | 2 | 1996 | 80 | 0.040 |
Why?
|
Thermodynamics | 1 | 2021 | 378 | 0.040 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2019 | 22 | 0.040 |
Why?
|
Machine Learning | 1 | 2022 | 316 | 0.040 |
Why?
|
RAW 264.7 Cells | 1 | 2019 | 41 | 0.040 |
Why?
|
Protein Transport | 1 | 2020 | 386 | 0.040 |
Why?
|
DNA (Cytosine-5-)-Methyltransferases | 1 | 2018 | 26 | 0.040 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2018 | 31 | 0.040 |
Why?
|
Cell Line | 3 | 1999 | 2581 | 0.040 |
Why?
|
Virus Diseases | 1 | 2000 | 192 | 0.040 |
Why?
|
Datasets as Topic | 1 | 2018 | 98 | 0.040 |
Why?
|
Retinal Dehydrogenase | 1 | 2017 | 33 | 0.030 |
Why?
|
Genetic Testing | 1 | 2019 | 381 | 0.030 |
Why?
|
Phosphate Transport Proteins | 1 | 1996 | 2 | 0.030 |
Why?
|
I-kappa B Proteins | 1 | 2017 | 75 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2017 | 88 | 0.030 |
Why?
|
Interphase | 1 | 1996 | 31 | 0.030 |
Why?
|
Hydrazines | 1 | 2016 | 27 | 0.030 |
Why?
|
Adenovirus Infections, Human | 1 | 1996 | 12 | 0.030 |
Why?
|
Bacillus megaterium | 1 | 2016 | 1 | 0.030 |
Why?
|
Heterografts | 1 | 2017 | 117 | 0.030 |
Why?
|
HeLa Cells | 2 | 2014 | 553 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2017 | 214 | 0.030 |
Why?
|
NADPH-Ferrihemoprotein Reductase | 1 | 2016 | 10 | 0.030 |
Why?
|
Symporters | 1 | 1996 | 52 | 0.030 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 2016 | 14 | 0.030 |
Why?
|
Acylation | 1 | 2016 | 28 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 387 | 0.030 |
Why?
|
Gliosarcoma | 1 | 2015 | 8 | 0.030 |
Why?
|
Transfection | 1 | 1998 | 842 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2019 | 802 | 0.030 |
Why?
|
COP9 Signalosome Complex | 1 | 2015 | 6 | 0.030 |
Why?
|
Drug Therapy | 1 | 2016 | 74 | 0.030 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2015 | 14 | 0.030 |
Why?
|
Granulocyte Precursor Cells | 1 | 2015 | 7 | 0.030 |
Why?
|
Dimerization | 1 | 2015 | 175 | 0.030 |
Why?
|
DNA Primers | 1 | 1996 | 496 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2015 | 134 | 0.030 |
Why?
|
Dihydrolipoyllysine-Residue Acetyltransferase | 1 | 2014 | 6 | 0.030 |
Why?
|
Ketone Oxidoreductases | 1 | 2014 | 7 | 0.030 |
Why?
|
DNA Damage | 1 | 2017 | 345 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2014 | 55 | 0.030 |
Why?
|
Imatinib Mesylate | 1 | 2014 | 62 | 0.030 |
Why?
|
Immunotherapy | 1 | 2018 | 472 | 0.030 |
Why?
|
Down-Regulation | 1 | 2017 | 593 | 0.030 |
Why?
|
Kinetics | 2 | 2011 | 1528 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2017 | 786 | 0.030 |
Why?
|
Ionomycin | 1 | 2014 | 23 | 0.030 |
Why?
|
Fetal Blood | 1 | 1996 | 266 | 0.030 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2015 | 70 | 0.030 |
Why?
|
Lethal Dose 50 | 1 | 2014 | 12 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2015 | 306 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 372 | 0.030 |
Why?
|
Splenomegaly | 1 | 2014 | 15 | 0.030 |
Why?
|
Child | 4 | 2020 | 18340 | 0.030 |
Why?
|
Zinc Finger Protein GLI1 | 1 | 2014 | 21 | 0.030 |
Why?
|
Dyspnea | 1 | 2016 | 211 | 0.030 |
Why?
|
Cyclin D1 | 2 | 2005 | 61 | 0.030 |
Why?
|
Arachidonic Acids | 1 | 2014 | 56 | 0.030 |
Why?
|
Fatigue | 1 | 2016 | 292 | 0.030 |
Why?
|
Superoxides | 1 | 2014 | 186 | 0.030 |
Why?
|
Amino Acids, Aromatic | 1 | 2014 | 8 | 0.030 |
Why?
|
Pre-B-Cell Leukemia Transcription Factor 1 | 1 | 2013 | 6 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2005 | 104 | 0.030 |
Why?
|
Phosphorothioate Oligonucleotides | 1 | 2013 | 9 | 0.030 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2014 | 31 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 1998 | 777 | 0.030 |
Why?
|
Idarubicin | 1 | 2013 | 3 | 0.030 |
Why?
|
Serine | 1 | 2014 | 124 | 0.030 |
Why?
|
Fetus | 2 | 1995 | 697 | 0.030 |
Why?
|
Transplant Recipients | 1 | 2015 | 130 | 0.030 |
Why?
|
MCF-7 Cells | 1 | 2014 | 104 | 0.030 |
Why?
|
Drug Administration Routes | 1 | 2013 | 38 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2018 | 686 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2013 | 78 | 0.030 |
Why?
|
Biocatalysis | 1 | 2013 | 58 | 0.030 |
Why?
|
HIV-1 | 1 | 1999 | 764 | 0.030 |
Why?
|
Pandemics | 1 | 2021 | 1308 | 0.030 |
Why?
|
Ribavirin | 1 | 2014 | 89 | 0.030 |
Why?
|
Survival Analysis | 1 | 2016 | 1203 | 0.030 |
Why?
|
Caspases | 1 | 2014 | 236 | 0.030 |
Why?
|
Time Factors | 4 | 2004 | 6032 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2018 | 960 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 435 | 0.030 |
Why?
|
Infant | 3 | 2015 | 7922 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 382 | 0.030 |
Why?
|
Urban Population | 1 | 2015 | 393 | 0.030 |
Why?
|
Adolescent | 3 | 2019 | 17724 | 0.030 |
Why?
|
Escherichia coli | 1 | 2016 | 712 | 0.030 |
Why?
|
Doxorubicin | 1 | 2013 | 283 | 0.030 |
Why?
|
Risk Factors | 2 | 2016 | 8606 | 0.030 |
Why?
|
Transcription Factor RelB | 1 | 2012 | 3 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 2077 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2012 | 126 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2014 | 2293 | 0.020 |
Why?
|
Cell Size | 1 | 2012 | 79 | 0.020 |
Why?
|
Graft Rejection | 1 | 2015 | 508 | 0.020 |
Why?
|
Stromal Cells | 1 | 2012 | 95 | 0.020 |
Why?
|
Proto-Oncogenes | 1 | 1991 | 26 | 0.020 |
Why?
|
Farnesyltranstransferase | 1 | 2011 | 21 | 0.020 |
Why?
|
Immunocompetence | 1 | 2011 | 40 | 0.020 |
Why?
|
Benzenesulfonates | 1 | 2011 | 19 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 712 | 0.020 |
Why?
|
beta Catenin | 1 | 2013 | 208 | 0.020 |
Why?
|
Leukocyte Common Antigens | 1 | 2011 | 72 | 0.020 |
Why?
|
Cell Count | 1 | 2012 | 297 | 0.020 |
Why?
|
Diphosphonates | 1 | 2011 | 51 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 191 | 0.020 |
Why?
|
Bone Resorption | 1 | 2011 | 72 | 0.020 |
Why?
|
Bone Density Conservation Agents | 1 | 2011 | 62 | 0.020 |
Why?
|
Genetic Linkage | 1 | 1991 | 289 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 1114 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2016 | 733 | 0.020 |
Why?
|
Receptors, Fibronectin | 1 | 1990 | 4 | 0.020 |
Why?
|
Blotting, Southern | 1 | 1990 | 67 | 0.020 |
Why?
|
Imidazoles | 1 | 2011 | 203 | 0.020 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2010 | 31 | 0.020 |
Why?
|
Transplantation, Isogeneic | 1 | 1990 | 17 | 0.020 |
Why?
|
Receptor, Notch1 | 1 | 2010 | 59 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2013 | 1159 | 0.020 |
Why?
|
Antigens, Surface | 1 | 1990 | 145 | 0.020 |
Why?
|
Fibronectins | 1 | 1990 | 104 | 0.020 |
Why?
|
Thioredoxins | 1 | 2009 | 33 | 0.020 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2009 | 19 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 783 | 0.020 |
Why?
|
Amino Acid Sequence | 3 | 2005 | 1956 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 2010 | 91 | 0.020 |
Why?
|
Extracellular Space | 1 | 2009 | 115 | 0.020 |
Why?
|
Antibody Affinity | 1 | 2009 | 51 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2015 | 756 | 0.020 |
Why?
|
Pilot Projects | 1 | 2013 | 1356 | 0.020 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2009 | 98 | 0.020 |
Why?
|
Cell Adhesion | 1 | 1990 | 423 | 0.020 |
Why?
|
CD40 Ligand | 1 | 2008 | 37 | 0.020 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2009 | 57 | 0.020 |
Why?
|
Solubility | 1 | 2009 | 221 | 0.020 |
Why?
|
Lymphoma | 1 | 2009 | 176 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2010 | 220 | 0.020 |
Why?
|
Child, Preschool | 2 | 2015 | 9093 | 0.020 |
Why?
|
Genes, abl | 1 | 2008 | 3 | 0.020 |
Why?
|
Genes, p16 | 1 | 2008 | 16 | 0.020 |
Why?
|
MutL Protein Homolog 1 | 1 | 2008 | 9 | 0.020 |
Why?
|
Algorithms | 1 | 2015 | 1462 | 0.020 |
Why?
|
Pyridines | 1 | 2011 | 417 | 0.020 |
Why?
|
Interleukin-4 | 1 | 2008 | 202 | 0.020 |
Why?
|
B-Cell Activating Factor | 1 | 2007 | 18 | 0.020 |
Why?
|
Models, Immunological | 1 | 2008 | 89 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2009 | 402 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2008 | 132 | 0.020 |
Why?
|
Models, Chemical | 1 | 2009 | 246 | 0.020 |
Why?
|
Deoxycytidine | 1 | 2008 | 137 | 0.020 |
Why?
|
Granulocytes | 2 | 1999 | 75 | 0.020 |
Why?
|
Information Dissemination | 1 | 2009 | 185 | 0.020 |
Why?
|
Group V Phospholipases A2 | 1 | 2007 | 1 | 0.020 |
Why?
|
Graft Survival | 1 | 2009 | 441 | 0.020 |
Why?
|
Phospholipases A2 | 1 | 2007 | 72 | 0.020 |
Why?
|
Bone and Bones | 1 | 2009 | 275 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 521 | 0.020 |
Why?
|
Jagged-1 Protein | 1 | 2006 | 22 | 0.020 |
Why?
|
Serrate-Jagged Proteins | 1 | 2006 | 27 | 0.020 |
Why?
|
Hospitalization | 1 | 2015 | 1765 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 1465 | 0.020 |
Why?
|
Water | 1 | 2009 | 394 | 0.020 |
Why?
|
Antioxidants | 1 | 2009 | 527 | 0.020 |
Why?
|
Adenylyl Cyclases | 1 | 2006 | 82 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2010 | 515 | 0.020 |
Why?
|
Lipoproteins | 1 | 2007 | 157 | 0.020 |
Why?
|
Aging | 1 | 1995 | 1601 | 0.020 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 128 | 0.020 |
Why?
|
Reference Values | 1 | 2007 | 735 | 0.020 |
Why?
|
Ornithine Decarboxylase | 1 | 2005 | 8 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2008 | 380 | 0.020 |
Why?
|
Prospective Studies | 1 | 2016 | 6189 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2006 | 267 | 0.010 |
Why?
|
Ligands | 1 | 2006 | 553 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2005 | 349 | 0.010 |
Why?
|
Cytoplasm | 1 | 2005 | 246 | 0.010 |
Why?
|
Genes, myc | 1 | 2003 | 44 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2008 | 1110 | 0.010 |
Why?
|
Pregnancy | 2 | 1997 | 5490 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2003 | 254 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2003 | 154 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 1682 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2005 | 527 | 0.010 |
Why?
|
In Vitro Techniques | 1 | 2003 | 996 | 0.010 |
Why?
|
Tissue Donors | 1 | 2004 | 313 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2004 | 337 | 0.010 |
Why?
|
Virus Replication | 1 | 2004 | 392 | 0.010 |
Why?
|
CD24 Antigen | 1 | 1999 | 20 | 0.010 |
Why?
|
Stem Cell Factor | 1 | 1999 | 14 | 0.010 |
Why?
|
Leukapheresis | 1 | 1999 | 21 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2000 | 172 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 1999 | 70 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 1999 | 72 | 0.010 |
Why?
|
Tissue and Organ Harvesting | 1 | 1999 | 62 | 0.010 |
Why?
|
Macaca mulatta | 1 | 1999 | 130 | 0.010 |
Why?
|
Leukemia Virus, Murine | 1 | 1999 | 16 | 0.010 |
Why?
|
Congresses as Topic | 1 | 2000 | 194 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2004 | 1106 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2000 | 241 | 0.010 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 1998 | 17 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1998 | 75 | 0.010 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1998 | 138 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 1998 | 141 | 0.010 |
Why?
|
Transgenes | 1 | 1998 | 169 | 0.010 |
Why?
|
Transformation, Genetic | 1 | 1997 | 15 | 0.010 |
Why?
|
Sodium-Phosphate Cotransporter Proteins | 1 | 1996 | 10 | 0.010 |
Why?
|
3T3 Cells | 1 | 1997 | 133 | 0.010 |
Why?
|
Dendritic Cells | 1 | 1998 | 432 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 1999 | 757 | 0.010 |
Why?
|
Antibodies | 1 | 1994 | 354 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1999 | 1725 | 0.010 |
Why?
|
Muridae | 1 | 1991 | 5 | 0.010 |
Why?
|
Statistics as Topic | 1 | 1993 | 287 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1991 | 147 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 1991 | 135 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1991 | 190 | 0.010 |
Why?
|
Multigene Family | 1 | 1991 | 187 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1991 | 476 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1991 | 514 | 0.010 |
Why?
|
Thymus Gland | 1 | 1991 | 291 | 0.010 |
Why?
|
United States | 1 | 2000 | 12137 | 0.000 |
Why?
|